HCV+ hepatocytes induce human regulatory CD4+ T cells through the production of TGF-β

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Hall, Caroline H T ^a   Kassel, Rachel ^a   Tacke, Robert S ^a   Hahn, Young S ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR ALPHA; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; VIRUS PROTEIN;

ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER CELL; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; PHENOTYPE; PROTEIN INDUCTION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH17 CELL; UPREGULATION; BIOSYNTHESIS; CELL COUNT; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE; VIROLOGY;

HEPATITIS C VIRUS;

CELL COUNT; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, VIRAL; HEPACIVIRUS; HEPATOCYTES; HUMANS; INTERFERON-GAMMA; PHENOTYPE; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; VIRAL PROTEINS;

EID: 77957926607     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012154     Document Type: Article

References (44)

1. Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, et al. (1996) Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 98: 706-714.
2. Erickson AL, Kimura Y, Igarashi S, Eichelberger J, Houghton M, et al. (2001) The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity 15: 883-895.
3. Tester I, Smyk-Pearson S, Wang P, Wertheimer A, Yao E, et al. (2005) Immune evasion versus recovery after acute hepatitis C virus infection from a shared source. J Exp Med 201: 1725-1731.
4. Urbani S, Amadei B, Tola D, Massari M, Schivazappa S, et al. (2006) PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCVspecific CD8 exhaustion. J Virol 80: 11398-11403.
5. Nakamoto N, Cho H, Shaked A, Olthoff K, Valiga ME, et al. (2009) Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog 5: e1000313.
6. Cabrera R, Tu Z, Xu Y, Firpi RJ, Rosen HR, et al. (2004) An immuno modulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40: 1062-1071.
7. Perrella A, Vitiello L, Atripaldi L, Conti P, Sbreglia C, et al. (2006) Elevated CD4+/CD25+ T cell frequency and function during acute hepatitis C presage chronic evolution. Gut 55: 1370-1371.
8. Smyk-Pearson S, Golden-Mason L, Klarquist J, Burton JR Jr., Tester IA, et al. (2008) Functional suppression by FoxP3+CD4+CD25(high) regulatory T cells during acute hepatitis C virus infection. J Infect Dis 197: 46-57.
9. Yamagiwa S, Gray JD, Hashimoto S, Horwitz DA (2001) A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J Immunol 166: 7282-7289.
10. Marie JC, Letterio JJ, Gavin M, Rudensky AY (2005) TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J Exp Med 201: 1061-1067.
11. Murai M, Turovskaya O, Kim G, Madan R, Karp CL, et al. (2009) Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol 10: 1178-1184.
12. Kimura T, Saito T, Yoshimura M, Yixuan S, Baba M, et al. (2006) Association of transforming growth factor-beta 1 functional polymorphisms with natural clearance of hepatitis C virus. J Infect Dis 193: 1371-1374.
13. Taniguchi H, Kato N, Otsuka M, Goto T, Yoshida H, et al. (2004) Hepatitis C virus core protein upregulates transforming growth factor-beta 1 transcription. J Med Virol 72: 52-59.
14. Boudreau HE, Emerson SU, Korzeniowska A, Jendrysik MA, Leto TL (2009) Hepatitis C virus (HCV) proteins induce NADPH oxidase 4 expression in a transforming growth factor beta-dependent manner: a new contributor to HCV induced oxidative stress. J Virol 83: 12934-12946.
15. Lin W, Tsai WL, Shao RX, Wu G, Peng LF, et al. Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaB-dependent manner. Gastroenterology 138: 2509-2518, 2518 e2501.
16. Pavio N, Battaglia S, Boucreux D, Arnulf B, Sobesky R, et al. (2005) Hepatitis C virus core variants isolated from liver tumor but not from adjacent non-tumor tissue interact with Smad3 and inhibit the TGF-beta pathway. Oncogene 24: 6119-6132.
17. Warren A, Le Couteur DG, Fraser R, Bowen DG, McCaughan GW, et al. (2006) T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells. Hepatology 44: 1182-1190.
18. Rowell DL, Eckmann L, Dwinell MB, Carpenter SP, Raucy JL, et al. (1997) Human hepatocytes express an array of proinflammatory cytokines after agonist stimulation or bacterial invasion. Am J Physiol 273: G322-G332.
19. Correia MP, Cardoso EM, Pereira CF, Neves R, Uhrberg M, et al. (2009) Hepatocytes and IL-15: a favorable microenvironment for T cell survival and CD8+ T cell differentiation. J Immunol 182: 6149-6159.
20. Sawa Y, Arima Y, Ogura H, Kitabayashi C, Jiang JJ, et al. (2009) Hepatic interleukin-7 expression regulates T cell responses. Immunity 30: 447-457.
21. Messi M, Giacchetto I, Nagata K, Lanzavecchia A, Natoli G, et al. (2003) Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes. Nat Immunol 4: 78-86.
22. Selvaraj RK, Geiger TL (2007) A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta. J Immunol 179: 11 p following 1390.
23. Friedline RH, Brown DS, Nguyen H, Kornfeld H, Lee J, et al. (2009) CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance. J Exp Med 206: 421-434.
24. Tran DQ, Andersson J, Hardwick D, Bebris L, Illei GG, et al. (2009) Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures. Blood 113: 5125-5133.
25. Mucida D, Kutchukhidze N, Erazo A, Russo M, Lafaille JJ, et al. (2005) Oral tolerance in the absence of naturally occurring Tregs. J Clin Invest 115: 1923-1933.
26. Tarantino G, Coppola A, Conca P, Cimino E, Di Minno G (2008) Can serum TGF-beta 1 be used to evaluate the response to antiviral therapy of haemophilic patients with HCV-related chronic hepatitis? Int J Immunopathol Pharmacol 21: 1007-1012.
27. Marek B, Kajdaniuk D, Mazurek U, Janczewska-Kazek E, Kos-Kudla B, et al. (2005) TGF-beta1 mRNA expression in liver biopsy specimens and TGF-beta1 serum levels in patients with chronic hepatitis C before and after antiviral therapy. J Clin Pharm Ther 30: 271-277.
28. Blight KJ, McKeating JA, Rice CM (2002) Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 76: 13001-13014.
29. Yao ZQ, Eisen-Vandervelde A, Waggoner SN, Cale EM, Hahn YS (2004) Direct binding of hepatitis C virus core to gC1qR on CD4+ and CD8+ T cells leads to impaired activation of Lck and Akt. J Virol 78: 6409-6419.
30. Boettler T, Spangenberg HC, Neumann-Haefelin C, Panther E, Urbani S, et al. (2005) T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 79: 7860-7867.
31. Ebinuma H, Nakamoto N, Li Y, Price DA, Gostick E, et al. (2008) Identification and in vitro expansion of functional antigen-specific CD25+ FoxP3+ regulatory T cells in hepatitis C virus infection. J Virol 82: 5043-5053.
32. Leroy V, Bourliere M, Durand M, Abergel A, Tran A, et al. (2002) The antibody response to hepatitis B virus vaccination is negatively influenced by the hepatitis C virus viral load in patients with chronic hepatitis C: a case-control study. Eur J Gastroenterol Hepatol 14: 485-489.
33. Wiedmann M, Liebert UG, Oesen U, Porst H, Wiese M, et al. (2000) Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C. Hepatology 31: 230-234.
34. Pellicano R, Leone N, Berrutti M, Cutufia MA, Fiorentino M, et al. (2000) Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis. J Hepatol 33: 648-650.
35. Yakoob J, Jafri W, Hussainy AS (2003) Candida oesophagitis with hepatitis C virus: an uncommon association. Eur J Gastroenterol Hepatol 15: 701-703.
36. Fan TM, Kranz DM, Flavell RA, Roy EJ (2008) Costimulatory strength influences the differential effects of transforming growth factor beta1 for the generation of CD8+ regulatory T cells. Mol Immunol 45: 2937-2950.
37. Maeda H, Kuwahara H, Ichimura Y, Ohtsuki M, Kurakata S, et al. (1995) TGF-beta enhances macrophage ability to produce IL-10 in normal and tumorbearing mice. J Immunol 155: 4926-4932.
38. Fogel-Petrovic M, Long JA, Misso NL, Foster PS, Bhoola KD, et al. (2007) Physiological concentrations of transforming growth factor beta1 selectively inhibit human dendritic cell function. Int Immunopharmacol 7: 1924-1933.
39. Cottrez F, Groux H (2001) Regulation of TGF-beta response during T cell activation is modulated by IL-10. J Immunol 167: 773-778.
40. Gondek DC, Lu LF, Quezada SA, Sakaguchi S, Noelle RJ (2005) Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol 174: 1783-1786.
41. Weber SE, Harbertson J, Godebu E, Mros GA, Padrick RC, et al. (2006) Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo. J Immunol 176: 4730-4739.
42. Kakumu S, Fukatsu A, Shinagawa T, Kurokawa S, Kusakabe A (1992) Localisation of intrahepatic interleukin 6 in patients with acute and chronic liver disease. J Clin Pathol 45: 408-411.
43. Lemmers A, Moreno C, Gustot T, Marechal R, Degre D, et al. (2009) The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 49: 646-657.
44. Inagaki Y, Okazaki I (2007) Emerging insights into Transforming growth factor beta Smad signal in hepatic fibro-genesis. Gut 56: 284-292.